Outcomes

The available evidence on kisspeptin outcomes comes primarily from observational studies and early-phase clinical trials, with limited data from controlled interventional studies.

Reproductive and Endocrine Outcomes

Pubertal Development: Clinical trials have examined kisspeptin's role as a biomarker for pubertal onset, with one Phase 3 study investigating the relationship between kisspeptin signaling sensitivity and pubertal timing in boys (NCT03286517). However, specific outcome measures and results from this completed trial are not detailed in the available evidence.

Fertility Assessment: Completed studies have measured serum kisspeptin levels in infertile women (NCT03018314) and examined kisspeptin expression in reproductive tissues (NCT02877992), suggesting its potential as a diagnostic biomarker. The specific clinical correlations and predictive values are not specified in the available data.

Hormonal Response: Research indicates kisspeptin can stimulate measurable changes in reproductive hormone levels, with studies examining serum kisspeptin and DLK1 profiles during GnRH stimulation in precocious puberty conditions. The magnitude and clinical significance of these hormonal changes require further clarification.

Non-Reproductive Outcomes

Anti-inflammatory Effects: Preclinical evidence suggests kisspeptin-54 may reduce acute lung injury in septic conditions through AMPK-mediated suppression of NLRP3 inflammasome pathways. However, these findings are from animal models and their clinical relevance remains unestablished.

Receptor Response Patterns: Laboratory studies indicate different kisspeptin analogs produce varying degrees of receptor activation and tachyphylaxis, with the C6 analog showing greater transcriptional activation than kisspeptin-10 and -54 formulations.

Evidence Limitations

The strength of evidence for clinical outcomes is limited by several factors: most completed trials lack published results in the available literature; studies are predominantly observational or early-phase; and sample sizes and control groups are not well-characterized. Current recruiting trials (NCT07224490, NCT06545994) may provide additional outcome data but results are pending.

This information is for research purposes only and should not be used for medical decision-making without consultation with qualified healthcare providers.

Kisspeptin

Member access required